Incidence of hepatic veno‐occlusive disease ( · People undergoing stem cell transplant with haematological malignancies
It is very uncertain whether summary of findings: Glutamine changes incidence of hepatic veno‐occlusive disease ( compared with placebo (very low certainty).
1 finding from 1 review
Overall survival · People undergoing stem cell transplant with haematological malignancies
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality at 100 days post‐transplant · People undergoing stem cell transplant with haematological malignancies
It is very uncertain whether summary of findings: Glutamine changes all‐cause mortality at 100 days post‐transplant ( compared with placebo (very low certainty).
1 finding from 1 review
Mortality attributable to hepatic veno‐occlusive disease ( · People undergoing stem cell transplant with haematological malignancies
It is very uncertain whether summary of findings: Glutamine changes mortality attributable to hepatic veno‐occlusive disease ( compared with placebo (very low certainty).
1 finding from 1 review
Quality of life · People undergoing stem cell transplant with haematological malignancies
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Frequency of adverse events ( · People undergoing stem cell transplant with haematological malignancies
It is very uncertain whether summary of findings: Glutamine changes frequency of adverse events ( compared with placebo (very low certainty).
1 finding from 1 review
Adverse events · people with diabetes and foot ulcers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Development of any new foot ulcers · people with diabetes and foot ulcers
It is very uncertain whether arginine, glutamine and β‐hydroxy‐β‐methylbutyrate supplement changes development of any new foot ulcers compared with placebo (very low certainty).
1 finding from 1 review
Amputation · people with diabetes and foot ulcers
It is very uncertain whether arginine, glutamine and β‐hydroxy‐β‐methylbutyrate supplement changes amputation rate compared with placebo (very low certainty).
1 finding from 1 review
Ulcer healing · people with diabetes and foot ulcers
The review found no eligible studies for this question.
2 findings from 1 review
Quality of life · people with diabetes and foot ulcers
It is very uncertain whether arginine, glutamine and β‐hydroxy‐β‐methylbutyrate supplement changes quality of life compared with placebo (very low certainty).
1 finding from 1 review
All‐cause mortality during hospital stay · adult patients after liver transplantation.
It is very uncertain whether enteral nutrition via nasojejunal tube plus intravenous… changes death (during length of initial hospital stay; ITT) compared with standard parenteral nutrition (very low certainty).
1 finding from 1 review
Infection (ITT) ‐ mycotic infection · adult patients after liver transplantation.
It is very uncertain whether enteral nutrition via nasojejunal tube plus intravenous… changes infection (ITT) ‐ mycotic infection compared with standard parenteral nutrition (very low certainty).
1 finding from 1 review
Infection (ITT) ‐ infection (overall) · adult patients after liver transplantation.
It is very uncertain whether enteral nutrition via nasojejunal tube plus intravenous… changes infection (ITT) ‐ infection (overall) compared with standard parenteral nutrition (very low certainty).
1 finding from 1 review
Acute rejection · adult patients after liver transplantation.
It is very uncertain whether enteral nutrition via nasojejunal tube plus intravenous… changes acute rejection (ITT) compared with standard parenteral nutrition (very low certainty).
1 finding from 1 review
Length of hospital stay after liver transplantation [days] · adult patients after liver transplantation.
1 finding from 1 review
Intensive care unit length of stay after liver transplantation [days] (ITT) · adult patients after liver transplantation.
1 finding from 1 review
Days on ventilator · adult patients after liver transplantation.
1 finding from 1 review
1‐year‐survival · adult patients after liver transplantation.
It is very uncertain whether parenteral nutrition with alanyl‐glutamine, protein, fat,… changes 1‐year‐survival compared with 5% dextrose and normal saline (very low certainty).
1 finding from 1 review
3‐year‐survival · adult patients after liver transplantation.
It is very uncertain whether parenteral nutrition with alanyl‐glutamine, protein, fat,… changes 3‐year‐survival compared with 5% dextrose and normal saline (very low certainty).
1 finding from 1 review